Online Only Articles

Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a report by the French Belgian Swiss APL group (APL 2006 trial)

Hôpital Saint Louis, Université Paris Diderot, France
Hôpital Saint Louis, Université Paris Diderot, France
Hospices Civils de Lyon, Département d’Hématologie, Centre Hospitalier Lyon-Sud, Pierre Bénite, France
Hematology Department, Nancy University Hospital, France
Hematology Department, Bordeaux University Hospital, France
Institut Paoli Calmette, Marseille, France
Hôpital Saint Louis, Université Paris Diderot, France
Hematology Department, Versailles University Hospital, France
Hematology Department, University of Lausanne, CHUV, Switzerland
Deparment of Clinical and Experimental Hematology, Institut Jules Bordet (ULB), Brussels, Belgium
Hematology Department, Amiens University Hospital, France
Hematology Department, Caen University Hospital, France
Hematology Department, Limoges University Hospital, France
Service de Biostatistique et Information médicale, Hôpital Saint Louis, Université Paris Diderot, France
Service de Biostatistique et Information médicale, Hôpital Saint Louis, Université Paris Diderot, France
Hôpital Saint Louis, Université Paris Diderot, France
Vol. 103 No. 11 (2018): November, 2018 https://doi.org/10.3324/haematol.2018.193151